NCT00249951View on ClinicalTrials.gov

Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Nephrocalcinosis
Interventions
DRUG

Alkaline citrate

Prophylactic alkaline citrate medication during the first 8 weeks of life versus placebo solution to prevent nephrocalcinosis of prematurity.

Trial Locations (1)

D-50924

Prof. Dr. Bernd Hoppe, Cologne

All Listed Sponsors
lead

University of Cologne

OTHER

NCT00249951 - Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants | Biotech Hunter | Biotech Hunter